ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Condition:   Hemophilia A With Inhibitor Intervention:   Drug: SCT800 and Daratumumab Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Sinocelltech Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials